November 15th, 2019

Podcast 242: Tranexamic acid saves lives after traumatic bleeds

(2 votes, average: 2.00 out of 5)

Tranexamic acid, which frustrates clot dissolution, has been shown to reduce death from intracranial bleeding in a large international placebo-controlled trial — “CRASH-3.”

Ali Raja and Joe Elia host a lively chat with Ian Roberts, the co-chair of the trial’s writing committee, who, in addition to chastising the hosts’ seeming fascination with P-values, recounts a story from early in his training that first stirred his devotion to preventing bleeding-related death after trauma.

NEJM Journal Watch Emergency Medicine summary of CRASH-3

CRASH-3 report in The Lancet

Ian Roberts explains CRASH-3 on YouTube to collaborators in Malaysia

Roberts presents CRASH-3 results at World Congress on Intensive Care on YouTube

Running time: 23 minutes

2 Responses to “Podcast 242: Tranexamic acid saves lives after traumatic bleeds”

  1. DR. Firdousi Ahmed Ali Aljailani says:

    New England Journal Of Medicine is the most respected scientific medical journal worldwide

  2. Hamed Alkaff says:

    In all my cases with acute non-variceal bleeding and in dengue hemorrhagic fever (my country, Yemen, is currently an endemic area), I use tranexamic acid 500 mg IV bolus, followed by 500 mg (diluted in 100 ml normal saline) as a continuous IV infusion over 8 hrs only. … Seems like it works; and I didn’t recognize any thrombotic event.

Leave a Reply

Your email address will not be published. Required fields are marked *

Note: This is a moderated forum. By clicking on the "Submit Comment" button below, you agree to abide by the NEJM Journal Watch Terms of Use.

Our physician bloggers cannot respond to requests for personal medical advice, and recommend patients discuss health issues with their individual physicians.

Clinical Conversations

About the Podcast

To subscribe:

Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.